Published in Gene Therapy Weekly, January 24th, 2002
NASH, also called nonalcoholic fatty liver disease, is a disease of the obese or diabetic, and can produce liver damage similar to that observed in people who consume too much alcohol. Liver fibrosis and liver cirrhosis sometimes becomes apparent in some but not all patients with NASH.
Researchers at the University Hospital of Marques de Valdecilla in Spain have compared adipose and liver...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.